EMERYVILLE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage…
April 11, 2025 16:01 ET | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BridgeBio…
April 08, 2025 16:15 ET | Source: Myriad Genetics, Inc. SALT LAKE CITY, April 08, 2025 (GLOBE NEWSWIRE) -- Myriad…
April 07, 2025 17:21 ET | Source: Bluejay Diagnostics, Inc. ACTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics,…
April 07, 2025 17:00 ET | Source: Anika Therapeutics Inc. BEDFORD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics,…
April 04, 2025 16:05 ET | Source: Syndax Pharmaceuticals, Inc. NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals…
WESTLAKE VILLAGE, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing…
April 04, 2025 16:30 ET | Source: Xilio Therapeutics, Inc. WALTHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics,…
April 02, 2025 16:30 ET | Source: Olema Oncology SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc.…
CAMBRIDGE, Mass., March 21, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and…